Firsthand Technology Value Fund, Inc. (SVVC) Reaches $10.09 52-Week High; American Petroleum Group (AMPE) Sentiment Is 0.55

January 14, 2018 - By Dolores Ford

The stock of Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC) hit a new 52-week high and has $10.80 target or 7.00% above today’s $10.09 share price. The 5 months bullish chart indicates low risk for the $74.98 million company. The 1-year high was reported on Jan, 14 by Barchart.com. If the $10.80 price target is reached, the company will be worth $5.25M more. The stock increased 2.64% or $0.26 during the last trading session, reaching $10.09. About 66,226 shares traded or 107.86% up from the average. Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC) has risen 11.85% since January 14, 2017 and is uptrending. It has underperformed by 4.85% the S&P500.

Ampio Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company has market cap of $222.51 million. The firm is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. It currently has negative earnings. The Company’s product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee; and Optina, which has completed Phase II clinical trials for diabetic macular edema.

Knoll Capital Management Lp holds 1.38% of its portfolio in Ampio Pharmaceuticals, Inc. for 2.60 million shares. Noven Financial Group Inc. owns 245,667 shares or 0.09% of their US portfolio. Moreover, Cypress Capital Management Llc (Wy) has 0.05% invested in the company for 72,000 shares. The Colorado-based Ghp Investment Advisors Inc. has invested 0.01% in the stock. Bank Of America Corp De, a North Carolina-based fund reported 15,037 shares.

The stock increased 0.34% or $0.01 during the last trading session, reaching $2.93. About 1.02 million shares traded. Ampio Pharmaceuticals, Inc. (AMPE) has declined 79.44% since January 14, 2017 and is downtrending. It has underperformed by 96.14% the S&P500.

Investors sentiment decreased to 0.75 in Q3 2017. Its down 0.58, from 1.33 in 2017Q2. It worsened, as 4 investors sold Firsthand Technology Value Fund, Inc. shares while 4 reduced holdings. 2 funds opened positions while 4 raised stakes. 1.28 million shares or 6.47% less from 1.37 million shares in 2017Q2 were reported. Bulldog Investors Ltd reported 0.49% in Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC). Equitec Proprietary Markets Lc, Illinois-based fund reported 36,110 shares. Reilly Fin Limited Liability Co has 0% invested in Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC). M Securities owns 26,000 shares. Clough Prns Lp has 0.01% invested in Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC) for 22,400 shares. Moreover, City Of London Inv Co Ltd has 0.03% invested in Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC). Tower Research Capital Lc (Trc) reported 458 shares. Plante Moran Fincl Advsrs Ltd Limited Liability Company holds 0% or 20 shares. Blue Bell Private Wealth Mngmt Lc reported 7 shares. Wells Fargo & Company Mn, a California-based fund reported 768,789 shares. Pathstone Family Office Ltd Com stated it has 81 shares or 0% of all its holdings. Next holds 0% or 18 shares in its portfolio. Yakira stated it has 30,064 shares. Moreover, Natl Bank Of Montreal Can has 0% invested in Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC) for 308 shares. Morgan Stanley stated it has 0% in Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>